文献速递临床微生物分子诊断质量管理与危急值

Accelerate Pheno系统用于阳性血培养病原体鉴定与药敏试验:时效与流程影响

Use of the Accelerate Pheno System for Identification and Antimicrobial Susceptibility Testing of Pathogens in Positive Blood Cultures and Impact on Time to Results and Workflow.
PubMed 文献 · J Clin Microbiol · 2017-12-26

该研究评估Accelerate Pheno系统在临床微生物实验室中对阳性血培养标本进行细菌和酵母菌鉴定及细菌药敏试验的准确性与工作流程。共分析232份血培养(223份单微生物,9份多微生物)共241株病原体,鉴定总体灵敏度和特异度分别为95.6%和99.5%,药敏总体基本一致率为95.1%,分类一致率为95.5%。与常规方法相比,鉴定和药敏结果时间分别缩短23.47小时和41.86小时,每份培养手工操作时间减少25.5分钟。

要点

  • Accelerate Pheno系统对阳性血培养常见病原体鉴定灵敏度95.6%、特异度99.5%。
  • 药敏基本一致率95.1%、分类一致率95.5%,出现1个极重大错误和3个重大错误。
  • 鉴定和药敏结果时间分别缩短23.47小时和41.86小时,手工操作时间减少25.5分钟/份。

核心结论

  • Accelerate Pheno系统能为阳性血培养中大多数常规病原体提供快速准确的鉴定和药敏结果,并显著缩短结果报告时间。

研究设计与样本

  • 研究连续纳入实验室接收的新鲜血培养标本,在生长检测后0至8小时内用Accelerate Pheno系统分析,并与常规标准方法比较鉴定/药敏性能、平均结果时间和工作流程。
  • 共评估232份血培养(223份单微生物和9份多微生物),涵盖241株病原体。

主要发现

  • 鉴定总体灵敏度为95.6%,总体特异度为99.5%。
  • 药敏总体基本一致率为95.1%,分类一致率为95.5%,出现1个极重大错误和3个重大错误。
  • 与常规方法相比,鉴定时间缩短23.47小时,药敏时间缩短41.86小时,每份培养手工操作时间减少25.5分钟。

临床怎么用

  • 该系统易于使用,可减少常见血病原体鉴定/药敏的手工操作时间,并比当前标准方法更早释放具有临床指导意义的结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Accelerate Pheno system uses automated fluorescence in situ hybridization technology with morphokinetic cellular analysis to provide rapid species identification (ID) and antimicrobial susceptibility testing (AST) results for the most commonly identified organisms in bloodstream infections. The objective was to evaluate the accuracy and workflow of bacterial and yeast ID and bacterial AST using the Accelerate Pheno system in the clinical microbiology laboratory. The consecutive fresh blood cultures received in the laboratory were analyzed by the Accelerate Pheno system within 0 to 8 h of growth detection. ID/AST performance, the average times to results, and workflow were compared to those of the routine standard of care. Of the 232 blood cultures evaluated (223 monomicrobial and 9 polymicrobial) comprising 241 organisms, the overall sensitivity and specificity for the identification of organisms were 95.6% and 99.5%, respectively. For antimicrobial susceptibility, the overall essential agreement was 95.1% and categorical agreement was 95.5% compared to routine methods. There was one very major error and 3 major errors. The time to identification and the time to susceptibility using the Accelerate Pheno system were decreased by 23.47 and 41.86 h, respectively, compared to those for the standard of care. The reduction in hands on time was 25.5 min per culture. The Accelerate Pheno system provides rapid and accurate ID/AST results for most of the organisms found routinely in blood cultures. It is easy to use, reduces hands on time for ID/AST of common blood pathogens, and enables clinically actionable results to be released much earlier than with the current standard of care.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Charnot-Katsikas A, Tesic V, Love N, et al. Use of the Accelerate Pheno System for Identification and Antimicrobial Susceptibility Testing of Pathogens in Positive Blood Cultures and Impact on Time to Results and Workflow. J Clin Microbiol. 2017. PMID: 29118168. doi:10.1128/JCM.01166-17

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。